Michael C Charette is a pharmacist who is specialized in Psychiatric in Bedford, Massachusetts. Patients can reach him at 182 North Rd, Bedford or contact him on 617-276-7879. Active license number of Michael C Charette is 18300 for Psychiatric in Massachusetts. Michael C Charette is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Michael C Charette speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Michael C Charette
Specialization:
Psychiatric
Credentials:
RPH
Gender:
Male
Location:
182 North Rd, Bedford, Massachusetts, 01730-1024
Phone:
617-276-7879
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Michael C Charette are as mentioned below.
NPI Number:
1740518844
NPI Enumeration Date:
01 Dec, 2009
NPI Last Update On:
01 Dec, 2009
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael C Charette are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
18300
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
182 North Rd, Bedford, Massachusetts
Zip:
01730-1024
Phone Number:
--
Fax Number:
--
Patients can reach Michael C Charette at 182 North Rd, Bedford, Massachusetts or can call on phone at 617-276-7879.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.